The Beauty Health Company
NASDAQ:SKIN
1.51 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 90.594 | 81.403 | 96.8 | 97.4 | 117.5 | 86.3 | 98.133 | 88.792 | 103.536 | 75.415 | 77.889 | 68.147 | 66.508 | 47.542 | 37.88 | 34.56 | 14.116 | 32.536 | 49.922 |
| Cost of Revenue
| 49.654 | 33.042 | 51.1 | 110 | 49.6 | 32.2 | 32.959 | 27.217 | 31.882 | 23.478 | 21.128 | 22.072 | 19.257 | 15.802 | 14.843 | 13.603 | 9.84 | 13.607 | 18.966 |
| Gross Profit
| 40.94 | 48.361 | 45.7 | -12.6 | 67.9 | 54.1 | 65.174 | 61.575 | 71.654 | 51.937 | 56.761 | 46.075 | 47.251 | 31.74 | 23.037 | 20.957 | 4.276 | 18.929 | 30.956 |
| Gross Profit Ratio
| 0.452 | 0.594 | 0.472 | -0.129 | 0.578 | 0.627 | 0.664 | 0.693 | 0.692 | 0.689 | 0.729 | 0.676 | 0.71 | 0.668 | 0.608 | 0.606 | 0.303 | 0.582 | 0.62 |
| Reseach & Development Expenses
| 1.159 | 2.807 | 3 | 1.8 | 2.9 | 2.3 | 1.446 | 2.167 | 2.601 | 2.23 | 1.875 | 1.88 | 2.988 | 1.452 | 0.86 | 0.577 | 0.597 | 1.376 | 1.252 |
| General & Administrative Expenses
| 31.41 | 28.861 | 28.975 | 37 | 35.1 | 30.4 | 28.472 | 23.782 | 27.585 | 26.261 | 25.045 | 19.2 | 44.402 | 10.811 | 10.99 | 7.054 | 5.412 | 7.192 | 6.513 |
| Selling & Marketing Expenses
| 30.482 | 33.684 | 32.025 | 30.7 | 43 | 38.7 | 39.021 | 39.767 | 44.881 | 36.407 | 37.053 | 30.451 | 26.214 | 17.095 | 15.898 | 10.541 | 6.186 | 17.697 | 16.807 |
| SG&A
| 61.892 | 62.545 | 61 | 67.7 | 78.1 | 69.1 | 67.493 | 63.549 | 72.466 | 62.668 | 62.098 | 49.651 | 70.616 | 27.906 | 26.888 | 17.595 | 11.598 | 24.889 | 23.32 |
| Other Expenses
| 17.319 | 16.087 | -0.137 | 4.9 | 0.047 | 0.4 | -1.27 | 2.509 | 1.658 | -0.937 | -0.16 | -10.551 | -40.832 | -0.007 | -0.131 | 0.023 | 0.056 | 0.005 | 0 |
| Operating Expenses
| 63.051 | 65.352 | 64 | 69.5 | 81 | 71.4 | 68.939 | 65.716 | 75.067 | 64.898 | 63.973 | 51.531 | 73.604 | 29.358 | 27.748 | 18.172 | 12.195 | 26.265 | 23.879 |
| Operating Income
| -22.111 | -16.991 | -18.3 | -82.1 | -13.1 | -17.3 | -5.154 | -4.141 | -1.755 | -12.961 | -7.212 | -5.456 | -26.353 | 2.382 | -4.711 | 2.785 | -7.919 | -7.336 | 6.384 |
| Operating Income Ratio
| -0.244 | -0.209 | -0.189 | -0.843 | -0.111 | -0.2 | -0.053 | -0.047 | -0.017 | -0.172 | -0.093 | -0.08 | -0.396 | 0.05 | -0.124 | 0.081 | -0.561 | -0.225 | 0.128 |
| Total Other Income Expenses Net
| 21.96 | 15.653 | 9.5 | 8.5 | 12 | -8.6 | 7.747 | 3.451 | 9.762 | 48.083 | -5.548 | -210.288 | -112.835 | -0.263 | -0.002 | 0.037 | 0.137 | -0.198 | -3.664 |
| Income Before Tax
| -0.151 | -1.338 | -8.8 | -70.3 | 1.2 | -25.9 | 2.593 | -0.69 | 8.007 | 35.122 | -16.248 | -216.274 | -141.248 | -3.58 | -10.541 | -2.807 | -13.449 | -11.684 | 2.72 |
| Income Before Tax Ratio
| -0.002 | -0.016 | -0.091 | -0.722 | 0.01 | -0.3 | 0.026 | -0.008 | 0.077 | 0.466 | -0.209 | -3.174 | -2.124 | -0.075 | -0.278 | -0.081 | -0.953 | -0.359 | 0.054 |
| Income Tax Expense
| -0.353 | -0.659 | 0.6 | 3.5 | -2.2 | -3.7 | -1.222 | -0.821 | 0.076 | 2.615 | 1.063 | -1.129 | -1.87 | -0.306 | -3.048 | -0.593 | -3.052 | -2.614 | 0.013 |
| Net Income
| 0.202 | -0.679 | -9.4 | -73.8 | 3.364 | -22.2 | 3.815 | 0.131 | 6.317 | 31.455 | -17.311 | -215.145 | -139.378 | -3.274 | -7.493 | -2.214 | -10.397 | -9.07 | 2.545 |
| Net Income Ratio
| 0.002 | -0.008 | -0.097 | -0.758 | 0.029 | -0.257 | 0.039 | 0.001 | 0.061 | 0.417 | -0.222 | -3.157 | -2.096 | -0.069 | -0.198 | -0.064 | -0.737 | -0.279 | 0.051 |
| EPS
| 0.002 | -0.006 | -0.073 | -0.56 | 0.025 | -0.17 | 0.028 | 0.001 | 0.042 | 0.21 | -0.12 | -1.63 | -1.52 | -0.026 | -0.06 | -0.018 | -0.083 | -0.072 | 51.72 |
| EPS Diluted
| -0.1 | -0.005 | -0.073 | -0.56 | 0.025 | -0.17 | 0.028 | 0.001 | 0.042 | 0.21 | -0.12 | -1.63 | -1.52 | -0.026 | -0.06 | -0.018 | -0.083 | -0.072 | 51.72 |
| EBITDA
| -13.194 | -8.343 | -8.4 | -70.5 | -7.4 | -12.5 | 0.53 | -1.632 | 2.835 | -7.849 | -7.372 | -16.007 | -67.185 | 6.019 | -1.349 | 6.478 | -4.094 | -3.862 | 10.057 |
| EBITDA Ratio
| -0.146 | -0.102 | -0.087 | -0.724 | -0.063 | -0.145 | 0.005 | -0.018 | 0.027 | -0.104 | -0.095 | -0.235 | -1.01 | 0.127 | -0.036 | 0.187 | -0.29 | -0.119 | 0.201 |